Genetic testing of embryos for women aged 37-41
Part of Women’s health & pregnancy clinical trials.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 37 and 41 years old.
- You have a male partner, a female partner, or are using sperm from a donor.
- Your AMH level (ovarian reserve test) is at least 6.28 pmol/L, measured within the past year.
- This will be your first to fifth IVF/ICSI cycle (cycles before a successful birth don't count).
- You do not need special genetic testing for chromosome rearrangements or single-gene disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study compares two ways of preparing sperm for IVF (a microfluidic chip versus a centrifuge method). It aims to see which method leads to more genetically normal embryos (euploid) when doing PGT (pre-implantation genetic testing).
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This study tests a new way to collect eggs without using fertility hormones, then fertilize them and freeze the embryos for later transfer. It may help women who want to avoid hormone injections, but it requires several monitoring visits and specific health criteria.
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
This study looks at how well a genetic test on embryos (called PGT-M) can find specific single-gene disorders. It will help doctors learn more about these tests and improve care for families.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.